Therapeutic Management of Hypertension: Special Populations

Learning Objectives

• Distinguish between severe hypertension and a hypertensive emergency and provide an appropriate treatment regimen for each situation.

• Recommend appropriate pharmacotherapy in special populations for the management of hypertension.

• Understand the importance of patient education and be able to provide patient education for a given patient.

Acute Elevated Hypertension Overview

• Definition: An acute severe elevation in blood pressure (BP) defined as BP > 180/120\,mmHg.

  • Systolic BP (SBP) > 180\,mmHg and/or diastolic BP (DBP) > 120\,mmHg.

• Associated Symptoms: Chest pain, shortness of breath, back pain, numbness, weakness, change in vision, or difficulty speaking.

• Categorization:

  • Severe Hypertension:

    • Elevation in BP > 180/120\,mmHg.

    • Not life-threatening.

    • Lack of progressive target organ damage (TOD).

    • Action: If no symptoms are present, call a healthcare provider.

  • Hypertensive Emergency:

    • Elevation in BP > 180/120\,mmHg.

    • Potentially life-threatening.

    • Impending or progressive acute target organ damage.

    • Action: Call 911 immediately if symptoms are present.

Target Organ Damage and Causes of Hypertensive Crisis

• Target Organ Damage (TOD) Signs:

  • Central Nervous System (CNS): Seizures, stroke, encephalopathy.

  • Heart: Acute coronary syndrome (e.g., myocardial infarction/heart attack), aortic dissection, acute heart failure.

  • Lung: Acute shortness of breath, pulmonary edema.

  • Kidney: Acute kidney injury (AKI), acute increase in serum creatinine, proteinuria.

  • Eyes: Blurred/loss of vision, retinopathy.

• Common Causes of Hypertensive Crisis:

  • Main Cause: Non-adherence to antihypertensive regimen.

  • Overdose: Cocaine, amphetamines, or stimulant diet pills.

  • Withdrawal Syndromes: Sudden cessation of Clonidine or beta-blockers.

  • Medical Conditions: Pheochromocytoma or complications during Pregnancy.

Cerebral Autoregulation

• Cerebral autoregulation is the ability of the cerebral vasculature to maintain stable blood flow during blood pressure changes.

• The brain is highly sensitive to overperfusion.

• Chronic Hypertension Shift: In patients with chronic HTN, the autoregulation curve shifts to the right.

  • This shift allows HTN patients to avoid excessive blood flow at higher BP levels and maintain normal perfusion.

  • Risk of Abrupt Lowering: Rapidly decreasing BP can precipitate ischemia in the brain (stroke), heart (heart attack), kidney (acute kidney injury), or cause syncope.

  • This is the physiologic basis for lowering BP gradually in severe HTN or hypertensive emergencies.

Management of Severe Hypertension

• Clinical Goal: Lower BP over hours to days (typically $24-48\,hours$).

  • Reduction of BP by > 25\% is associated with increased mortality.

  • Aggressive lowering is avoided to prevent hypoperfusion risk.

• Setting: Primarily outpatient.

• Treatment Path:

  • Initiate, restart, or increase doses of oral antihypertensive medications.

  • Re-evaluate the patient within $7\,days$.

• Oral (PO) Treatment Options:

  • Captopril: $25\,mg$ PO or sublingual; may repeat in $1-2\,hours$. Onset: $15-30\,min$. Duration: $4-6\,hrs$. Note: Contraindicated in pregnancy.

  • Clonidine: $0.2\,mg$ loading dose, then titrate $0.1\,mg/hr$ up to $0.7\,mg$ total. Onset: $30-60\,min$. Duration: $6-8\,hrs$. Note: Risk of orthostasis; use caution in older patients.

  • Labetalol: $200-400\,mg$, may repeat every $3-4\,hours$. Onset: $20-120\,min$. Duration: $4-6\,hrs$. Note: Avoid in acute decompensated heart failure.

Management of Hypertensive Emergencies

• Clinical Goal: Lower BP over minutes to hours using IV medications to minimize organ damage.

• Treatment Parameters:

  • First Hour: Reduce SBP by no more than $25\%$ to maintain cerebral perfusion.

  • Next 2-6 Hours: Decrease to $160/100-110\,mmHg$.

  • Subsequent 24-48 Hours: Attempt gradual decreases toward the overarching goal BP.

• Setting: Hospitalization in the Intensive Care Unit (ICU) is necessary for monitoring.

Hypertensive Emergency: IV Pharmacotherapy Options

• Clevidipine: Initial dose $1-2\,mg/hr$ (max $21\,mg/hr$ for $72\,hrs$). Onset: $2-4\,min$. Duration: $5-15\,min$. Preferred for acute pulmonary edema. Contraindicated in egg and soybean allergy.

• Enalaprilat: $1.25-5\,mg$ every $6\,hrs$. Onset: $15-30\,min$. Duration: $6\,hrs$. Contraindicated in pregnancy. Avoid in acute MI and renal artery stenosis.

• Esmolol: $500-1000\,mcg/kg/min$ over $1\,min$ followed by $50\,mcg/kg/min$ infusion. Onset: $1-2\,min$. Duration: $10-20\,min$. Preferred for aortic dissection to help lower Heart Rate (HR). Avoid in acute decompensated heart failure.

• Fenoldopam: $0.1-0.3\,mcg/kg/min$. Onset: <5\,min. Duration: $30\,min$. Dopamine agonist; safe with renal impairment.

• Hydralazine: $10-20\,mg$ bolus, repeat every $4-6\,hrs$. Onset: $10-20\,min$. Duration: $3-8\,hrs$. Typically reserved for eclampsia. Unpredictable response.

• Labetalol: $0.3-1\,mg/min$ slow IV injection. Onset: $5-10\,min$. Duration: $3-6\,hrs$. Preferred for aortic dissection.

• Nicardipine: $5-15\,mg/hr$. Onset: $5-10\,min$. Duration: $1-4\,hrs$. Versatile for most situations. Contraindicated in advanced aortic stenosis.

• Nitroglycerin: $5-200\,mcg/min$. Onset: $2-5\,min$. Duration: $3-5\,min$. Drug of Choice (DOC) for acute coronary syndrome (MI). Avoid if PDE-5 inhibitor used in past 24 hours (risk of severe hypotension).

• Sodium Nitroprusside: $0.3-0.5\,mcg/kg/min$ (Max $10\,mcg/kg/min$). Onset: Immediate. Duration: $1-2\,min$. First-line agent but risks thiocyanate/cyanide toxicity with renal dysfunction.

Preferred Drugs for Specific Comorbidities (ACC/AHA 2025)

• Acute Aortic Dissection: Esmolol, Labetalol. Requires rapid SBP lowering to $\le 120\,mmHg$ within $20\,min$. Beta blockade must precede vasodilator administration.

• Acute Pulmonary Edema: Clevidipine, Nitroglycerin, Nitroprusside. Beta-blockers are contraindicated.

• Acute Coronary Syndromes (ACS): Esmolol, Labetalol, Nicardipine, Nitroglycerin (Nitroglycerin is the agent of choice).

• Acute Kidney Injury (AKI): Clevidipine, Fenoldopam, Nicardipine.

• Eclampsia or Preeclampsia: Hydralazine, Labetalol, Nicardipine, Nifedipine. ACE inhibitors, ARBs, and Nitroprusside are contraindicated.

• Acute Ischemic Stroke / Intracerebral Hemorrhage (ICH): Clevidipine, Nicardipine, Esmolol, Labetalol, Hydralazine.

Hypertension and Pregnancy

• Chronic Hypertension: $BP \ge 140/90\,mmHg$ diagnosed before pregnancy or before $20\,weeks$' gestation.

• Gestational Hypertension: $BP \ge 140/90\,mmHg$ diagnosed at $\ge 20\,weeks$' gestation.

• Severe Hypertension (Pregnancy): $SBP \ge 160\,mmHg$ and/or $DBP \ge 110\,mmHg$.

• Treatment Goals: < 140/90\,mmHg.

• Pharmacotherapy:

  • First-line: Labetalol or Nifedipine ER.

  • Alternatives: Methyldopa (less effective), Hydrochlorothiazide.

  • AVOID: Atenolol, Spironolactone, Nitroprusside, ACE inhibitors, ARBs, and Aliskiren due to high fetal risk.

• Preeclampsia:

  • Defined as $BP \ge 140/90\,mmHg$ (twice, 4 hours apart) or $\ge 160/110\,mmHg$ (confirmed within $15\,min$) with proteinuria, edema, or organ damage.

  • Can progress to Eclampsia (convulsions/seizures).

  • Risk Reduction: Low-dose aspirin daily after the 1st trimester.

  • Acute Severe Treatment: IV Magnesium sulfate plus IV Hydralazine, IV Labetalol, or Oral Nifedipine IR.

Resistant Hypertension

• Definition: Failure to reach BP goal despite a 3-drug regimen at full doses (including a diuretic) OR needing $\ge 4$ drugs for control.

• Evaluation Factors:

  • Volume overload (excess sodium or kidney disease).

  • Adverse drug effects (NSAIDs, pseudoephedrine, steroids, illicit drugs).

  • Medical conditions (Primary aldosteronism, Thyroid/Parathyroid disease).

  • Pseudo-resistance: Poor measurement technique, white-coat HTN, or non-adherence.

• Management: Addition of an aldosterone receptor antagonist (e.g., Spironolactone or Eplerenone) is recommended.

Patient Education and Adherence

• Orthostatic Hypotension: Defined as significant BP drop upon standing. Higher risk in those $\ge 80\,years$ old and those taking Alpha1-receptor antagonists, diuretics, or nitrates.

• Factors for Non-Adherence: Treatment cost, lack of education, adverse effects, inconvenient dosing, and forgetfulness.

• Improvement Strategies:

  • Simplify regimens: Once-daily dosing or combination drugs.

  • Motivational strategies: Encourage home monitoring, set clear goals, and maintain contact via telecommunication.

• Counseling Pearls:

  • Use proper BP measurement techniques.

  • Implement DASH diet, restrict sodium, exercise, and stop smoking/alcohol.

  • Avoid OTC NSAIDs and pseudoephedrine.

Questions and Discussion

• Question 1: A 27-year-old woman at 20 weeks’ gestation presents with BP $152/96\,mmHg$. Urinalysis negative for protein; no symptoms. What is the initial therapy?

  • Response: Choice C (Labetalol) or D (Nifedipine ER, though the option says Nifedipine IR which is used for acute/preeclampsia). Labetalol is a standard first-line choice for non-severe gestational HTN.

• Question 2: A 58-year-old man, asymptomatic, BP $198/126\,mmHg$. No TOD. What is the management?

  • Response: Choice C. Start or adjust oral antihypertensive regimen today and schedule follow-up within a few days. This is severe hypertension (no symptoms/TOD), so IV therapy or ED referral is not required.

• Review Diagram Factors:

  • If BP >180/120 and TOD is YES: Type = Hypertensive Emergency; Setting = Hospital/ICU; Route = IV.

  • If BP >180/120 and TOD is NO: Type = Severe Hypertension; Setting = Outpatient; Route = Oral (PO).